Grant: Alliance Grants
Institut national de la recherche scientifique
$50,000.00
Sensitive and specific electrochemical detection of COVID-19 (SARS-CoV2) based on isothermal amplification_x000d_ _x000d_
FY 2020-21
Summary
The epidemic of the SARS-CoV2 virus (COVID-19) and its global spread urgently requires efficient means for rapid diagnosis, as well as detection in various environments (aside from clinical laboratories), such as airplanes, schools, potential animal carriers, etc. Indeed, most of the countries that appear to go through the current pandemic with currently relatively low death tolls and that are managing partial deconfinement are among those that are doing the most virus tests. We have previously devised a colorimetric method to detect specific virus DNA which could potentially be used for "on site" virus detection and which, in combination with an electrode-based detection device, would provide simple, sensitive and cheap on-site detection of the virus.
SARS-CoV2 (the pathogen causing COVID-19) is an RNA virus, which adds a step for its amplification with the most commonly used detection methods, compared to other viruses with a genome made of DNA. The method we want to implement detects RNA and DNA in a similar way. Moreover, the current gold standard for virus detection requires specialized laboratory material and personnel, which also means sample transportation logistics and waiting queues for samples to be processed. We aim at implementing a novel DNA amplification method (called Rolling Circle Amplification) which does not rely on specialized equipment. By combining this with electrodes we expect to achieve sensitive and rapid detection of the virus genome without the need for bulky complex devices.
Even if we all hope for a vaccine to come as soon as possible, there is still a dire need for an efficient, rapid and simple test to monitor, perhaps even on a daily or weekly basis, everyone who is going back to work or school to ensure that we can quickly respond to any new eclosion as soon as it can be detected. This would allow to have confinement measures targeted only on the workplaces with acknowledged COVID-19, but without affecting all work places and schools simultaneously.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
554464-2020
Name nom
Perreault, Jonathan
Department département
INRS-Institut Armand-Frappier, Centre
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Sensitive and specific electrochemical detection of COVID-19 (SARS-CoV2) based on isothermal amplification_x000d_
_x000d_
Keyword
NSERC
Application summary
The epidemic of the SARS-CoV2 virus (COVID-19) and its global spread urgently requires efficient means for rapid diagnosis, as well as detection in various environments (aside from clinical laboratories), such as airplanes, schools, potential animal carriers, etc. Indeed, most of the countries that appear to go through the current pandemic with currently relatively low death tolls and that are managing partial deconfinement are among those that are doing the most virus tests. We have previously devised a colorimetric method to detect specific virus DNA which could potentially be used for "on site" virus detection and which, in combination with an electrode-based detection device, would provide simple, sensitive and cheap on-site detection of the virus.
SARS-CoV2 (the pathogen causing COVID-19) is an RNA virus, which adds a step for its amplification with the most commonly used detection methods, compared to other viruses with a genome made of DNA. The method we want to implement detects RNA and DNA in a similar way. Moreover, the current gold standard for virus detection requires specialized laboratory material and personnel, which also means sample transportation logistics and waiting queues for samples to be processed. We aim at implementing a novel DNA amplification method (called Rolling Circle Amplification) which does not rely on specialized equipment. By combining this with electrodes we expect to achieve sensitive and rapid detection of the virus genome without the need for bulky complex devices.
Even if we all hope for a vaccine to come as soon as possible, there is still a dire need for an efficient, rapid and simple test to monitor, perhaps even on a daily or weekly basis, everyone who is going back to work or school to ensure that we can quickly respond to any new eclosion as soon as it can be detected. This would allow to have confinement measures targeted only on the workplaces with acknowledged COVID-19, but without affecting all work places and schools simultaneously.